WallStreetZenWallStreetZen

NASDAQ: FULC
Fulcrum Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Fulcrum Therapeutics earnings were -$73.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest FULC earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$17.3M, down 2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FULC reported annual earnings of -$9.7M, with -90% growth. The next FULC earnings date is Nov 12, 2025.

FULC earnings history

Current Revenue
$0.0
Current Earnings
-$73.2M
Current Profit Margin
0%

FULC Return on Equity

Current Company
-31%
Current Industry
-10%
Current Market
30.7%
FULC's Return on Equity (-31%)... subscribe to Premium to read more.
High Return on Equity Performance

FULC undefined

Current Company
-29%
Current Industry
-0.2%
FULC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when FULC announces earnings.

FULC undefined

Current Company
-33.3%
Current Industry
6.4%
FULC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FULC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
FULC-$71.78M-$73.22MN/A-$1.18
ABSI-$100.08M-$113.30MN/A-$0.95
AURA-$98.55M-$101.38MN/A-$1.96
ADCT-$115.26M-$169.94MN/A-$1.55
CGEM-$178.31M-$180.07MN/A-$2.66
View Top Biotech Stocks

FULC earnings dates

Next earnings date
Nov 12, 2025

Fulcrum Therapeutics Earnings Reports & History FAQ

What were Fulcrum Therapeutics's earnings last quarter?

On FULC's earnings call on Invalid Date, Fulcrum Therapeutics (NASDAQ: FULC) reported Q2 2025 earnings per share (EPS) of -$0.28, up 131.46% year over year. Total FULC earnings for the quarter were -$17.30 million. In the same quarter last year, Fulcrum Therapeutics's earnings per share (EPS) was $0.89.

If you're new to stock investing, here's how to buy Fulcrum Therapeutics stock.

When does Fulcrum Therapeutics report earnings?

The next FULC earnings date is Invalid Date. Add FULC to your watchlist to be reminded of Fulcrum Therapeutics's next earnings date.

Is Fulcrum Therapeutics profitable or losing money?

As of the last Fulcrum Therapeutics earnings report, Fulcrum Therapeutics is currently losing money. Fulcrum Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$73.22 million, a 261.84% increase year over year.

What was FULC's earnings growth in the past year?

As of Fulcrum Therapeutics's earnings date in Invalid Date, Fulcrum Therapeutics's earnings has grown year over year. FULC earnings in the past year totalled -$73.22 million.

What are Fulcrum Therapeutics's earnings expectations?

The current EPS estimate for Fulcrum Therapeutics's earnings report in Invalid Date is -$0.30.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.